IMAGE

Fig. 6

ID
ZDB-IMAGE-220824-60
Genes
Antibodies
Source
Figures for Halabi et al., 2022
Image
Figure Caption

Fig. 6

Disrupted heart valve development with the loss of Sema3fb. A, B Hematoxylin and eosin stained sections show the ventricle walls (yellow brackets) and valves (arrowheads within inset) of WT (A, A’) and sema3fbca305 embryos (B, B’) at 72 hpf. C, D Confocal projections of 72 hpf WT (C, C’) and mutant (D,D’) hearts immunolabeled by the myocardial marker MF20 (grey) on an endocardial-labeled transgenic line Tg(kdrl:mCherry). Brightness was increased in D’ to allow for comparison with C’. E, F nfatc1 ISH label in WT (E; N = 2, n = 13/13 normal) and sema3fbca305 (F, n = 13/15 short) 28 hpf embryos reveals a smaller endocardial domain (yellow bars). G, H nfatc1 concentration at the AVC (arrowheads) in WT (G, n = 21/21) and mutant (H, n = 16/17) 48 hpf fish. I-M AVC endocardial marker notch1b (I,J) (N = 2 WT n = 10/10; sema3fbca305 n = 10/10) and endocardial marker vegfr2 (M) (WT n = 10/12; sema3fbca305 n = 15/17) in 48 hpf hearts. Expansion of the tbx2b AVC cardiomyocyte marker in mutants (n = 7/8) that normally shows restricted expression at the AVC in WT hearts (n = 5/6) (K,L). N-P Quantitation of the: (1) length of the AV valve, as marked by mCherry in the Tg(kdrl:mCherry) background (N; N = 2, n = 10 sema3fb+/+, n = 12 sema3fbca305), (2) the ratio of the length of the valve present in the atrium to that measured in the ventricle at 72 hpf (O; p = 0.0003), and (3) the length of the nfatc1 domain (yellow bars, E and F) in 28 hpf WT (n = 13) and mutant (N = 15) embryos (P; p < 0.0001). Scale bars in A (A,B), A’ (A’,B’), C (C,D), C’ (C’,D’), E (E,F), G (G-M) are 50 µm

Figure Data
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cell Commun. Signal.